Author

Peter Bossuyt

Institution: Imelda Hospital

Observed institution: Imelda Hospital

OpenAlex ID: A5110817587

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

2021 · Laurent Peyrin-Biroulet, Ailsa Hart, et al. · The Lancet. Gastroenterology & hepatology · 101

Works count: 1

Citation count: 101

H-index: 1

I10-index: 1